カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のPARP阻害剤バイオマーカー試験製品市場2022年：検査キット、検査アッセイ

◆英語タイトル：Global PARP Inhibitor Biomarkers Testing Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8259 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：92 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

PARP阻害剤バイオマーカー試験製品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPARP阻害剤バイオマーカー試験製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

PARP阻害剤バイオマーカー試験製品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・検査キット、検査アッセイ

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界のPARP阻害剤バイオマーカー試験製品市場の主要な市場プレーヤーは以下のとおりです。
・Myriad Genetics, Inc.、Hoffmann-La Roche AG、Invitae Corporation、NeoGenomics Laboratories, Inc.、BPS Bioscience, Inc.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、PARP阻害剤バイオマーカー試験製品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPARP阻害剤バイオマーカー試験製品メーカーの企業概要、2019年～2022年までのPARP阻害剤バイオマーカー試験製品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPARP阻害剤バイオマーカー試験製品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別PARP阻害剤バイオマーカー試験製品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのPARP阻害剤バイオマーカー試験製品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPARP阻害剤バイオマーカー試験製品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPARP阻害剤バイオマーカー試験製品の産業チェーンを掲載しています。
・第13、14、15章では、PARP阻害剤バイオマーカー試験製品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Myriad Genetics, Inc.、Hoffmann-La Roche AG、Invitae Corporation、NeoGenomics Laboratories, Inc.、BPS Bioscience, Inc.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：検査キット、検査アッセイ
・用途別分析2017年-2028年：病院、クリニック、その他
・PARP阻害剤バイオマーカー試験製品の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・PARP阻害剤バイオマーカー試験製品のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・PARP阻害剤バイオマーカー試験製品のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・PARP阻害剤バイオマーカー試験製品の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・PARP阻害剤バイオマーカー試験製品の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PARP Inhibitor Biomarkers Testing Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PARP Inhibitor Biomarkers Testing Product market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the PARP Inhibitor Biomarkers Testing Product global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Testing Kits segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PARP Inhibitor Biomarkers Testing Product include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., and BPS Bioscience, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PARP Inhibitor Biomarkers Testing Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Testing Kits
Testing Assays
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global PARP Inhibitor Biomarkers Testing Product market are listed below:
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PARP Inhibitor Biomarkers Testing Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PARP Inhibitor Biomarkers Testing Product, with price, sales, revenue and global market share of PARP Inhibitor Biomarkers Testing Product from 2019 to 2022.
Chapter 3, the PARP Inhibitor Biomarkers Testing Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PARP Inhibitor Biomarkers Testing Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PARP Inhibitor Biomarkers Testing Product market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PARP Inhibitor Biomarkers Testing Product.
Chapter 13, 14, and 15, to describe PARP Inhibitor Biomarkers Testing Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 PARP Inhibitor Biomarkers Testing Product Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PARP Inhibitor Biomarkers Testing Product Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Testing Kits
1.2.3 Testing Assays
1.3 Market Analysis by Application
1.3.1 Overview: Global PARP Inhibitor Biomarkers Testing Product Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global PARP Inhibitor Biomarkers Testing Product Market Size & Forecast
1.4.1 Global PARP Inhibitor Biomarkers Testing Product Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PARP Inhibitor Biomarkers Testing Product Sales in Volume (2017-2028)
1.4.3 Global PARP Inhibitor Biomarkers Testing Product Price (2017-2028)
1.5 Global PARP Inhibitor Biomarkers Testing Product Production Capacity Analysis
1.5.1 Global PARP Inhibitor Biomarkers Testing Product Total Production Capacity (2017-2028)
1.5.2 Global PARP Inhibitor Biomarkers Testing Product Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PARP Inhibitor Biomarkers Testing Product Market Drivers
1.6.2 PARP Inhibitor Biomarkers Testing Product Market Restraints
1.6.3 PARP Inhibitor Biomarkers Testing Product Trends Analysis
2 Manufacturers Profiles
2.1 Myriad Genetics, Inc.
2.1.1 Myriad Genetics, Inc. Details
2.1.2 Myriad Genetics, Inc. Major Business
2.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
2.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hoffmann-La Roche AG
2.2.1 Hoffmann-La Roche AG Details
2.2.2 Hoffmann-La Roche AG Major Business
2.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product and Services
2.2.4 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Invitae Corporation
2.3.1 Invitae Corporation Details
2.3.2 Invitae Corporation Major Business
2.3.3 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product and Services
2.3.4 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 NeoGenomics Laboratories, Inc.
2.4.1 NeoGenomics Laboratories, Inc. Details
2.4.2 NeoGenomics Laboratories, Inc. Major Business
2.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
2.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BPS Bioscience, Inc.
2.5.1 BPS Bioscience, Inc. Details
2.5.2 BPS Bioscience, Inc. Major Business
2.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
2.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PARP Inhibitor Biomarkers Testing Product Breakdown Data by Manufacturer
3.1 Global PARP Inhibitor Biomarkers Testing Product Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PARP Inhibitor Biomarkers Testing Product
3.4 Market Concentration Rate
3.4.1 Top 3 PARP Inhibitor Biomarkers Testing Product Manufacturer Market Share in 2021
3.4.2 Top 6 PARP Inhibitor Biomarkers Testing Product Manufacturer Market Share in 2021
3.5 Global PARP Inhibitor Biomarkers Testing Product Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PARP Inhibitor Biomarkers Testing Product Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PARP Inhibitor Biomarkers Testing Product Market Size by Region
4.1.1 Global PARP Inhibitor Biomarkers Testing Product Sales in Volume by Region (2017-2028)
4.1.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2028)
4.2 North America PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028)
4.3 Europe PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028)
4.4 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028)
4.5 South America PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028)
4.6 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PARP Inhibitor Biomarkers Testing Product Sales in Volume by Type (2017-2028)
5.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
5.3 Global PARP Inhibitor Biomarkers Testing Product Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PARP Inhibitor Biomarkers Testing Product Sales in Volume by Application (2017-2028)
6.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
6.3 Global PARP Inhibitor Biomarkers Testing Product Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
7.2 North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
7.3 North America PARP Inhibitor Biomarkers Testing Product Market Size by Country
7.3.1 North America PARP Inhibitor Biomarkers Testing Product Sales in Volume by Country (2017-2028)
7.3.2 North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
8.2 Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
8.3 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Country
8.3.1 Europe PARP Inhibitor Biomarkers Testing Product Sales in Volume by Country (2017-2028)
8.3.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
9.2 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
9.3 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Region
9.3.1 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
10.2 South America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
10.3 South America PARP Inhibitor Biomarkers Testing Product Market Size by Country
10.3.1 South America PARP Inhibitor Biomarkers Testing Product Sales in Volume by Country (2017-2028)
10.3.2 South America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
11.2 Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
11.3 Middle East & Africa PARP Inhibitor Biomarkers Testing Product Market Size by Country
11.3.1 Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PARP Inhibitor Biomarkers Testing Product and Key Manufacturers
12.2 Manufacturing Costs Percentage of PARP Inhibitor Biomarkers Testing Product
12.3 PARP Inhibitor Biomarkers Testing Product Production Process
12.4 PARP Inhibitor Biomarkers Testing Product Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PARP Inhibitor Biomarkers Testing Product Typical Distributors
13.3 PARP Inhibitor Biomarkers Testing Product Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global PARP Inhibitor Biomarkers Testing Product Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PARP Inhibitor Biomarkers Testing Product Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Myriad Genetics, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Myriad Genetics, Inc. Major Business
Table 5. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
Table 6. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 8. Hoffmann-La Roche AG Major Business
Table 9. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product and Services
Table 10. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Invitae Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Invitae Corporation Major Business
Table 13. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product and Services
Table 14. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. NeoGenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. NeoGenomics Laboratories, Inc. Major Business
Table 17. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
Table 18. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BPS Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. BPS Bioscience, Inc. Major Business
Table 21. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product and Services
Table 22. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global PARP Inhibitor Biomarkers Testing Product Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global PARP Inhibitor Biomarkers Testing Product Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in PARP Inhibitor Biomarkers Testing Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global PARP Inhibitor Biomarkers Testing Product Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and PARP Inhibitor Biomarkers Testing Product Production Site of Key Manufacturer
Table 28. PARP Inhibitor Biomarkers Testing Product New Entrant and Capacity Expansion Plans
Table 29. PARP Inhibitor Biomarkers Testing Product Mergers & Acquisitions in the Past Five Years
Table 30. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022) & (K Units)
Table 31. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2023-2028) & (K Units)
Table 32. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022) & (USD Million)
Table 33. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028) & (USD Million)
Table 34. Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 35. Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 36. Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (USD Million)
Table 37. Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (USD Million)
Table 38. Global PARP Inhibitor Biomarkers Testing Product Price by Type (2017-2022) & (US$/Unit)
Table 39. Global PARP Inhibitor Biomarkers Testing Product Price by Type (2023-2028) & (US$/Unit)
Table 40. Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 41. Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 42. Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (USD Million)
Table 43. Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (USD Million)
Table 44. Global PARP Inhibitor Biomarkers Testing Product Price by Application (2017-2022) & (US$/Unit)
Table 45. Global PARP Inhibitor Biomarkers Testing Product Price by Application (2023-2028) & (US$/Unit)
Table 46. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
Table 47. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
Table 48. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (USD Million)
Table 49. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (USD Million)
Table 50. North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 51. North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 52. North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 53. North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 54. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
Table 55. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
Table 56. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 59. Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 60. Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 61. Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 70. South America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
Table 71. South America PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
Table 72. South America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (USD Million)
Table 73. South America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (USD Million)
Table 74. South America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 75. South America PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 76. South America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 77. South America PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
Table 86. PARP Inhibitor Biomarkers Testing Product Raw Material
Table 87. Key Manufacturers of PARP Inhibitor Biomarkers Testing Product Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. PARP Inhibitor Biomarkers Testing Product Typical Distributors
Table 91. PARP Inhibitor Biomarkers Testing Product Typical Customers
List of Figures
Figure 1. PARP Inhibitor Biomarkers Testing Product Picture
Figure 2. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type in 2021
Figure 3. Testing Kits
Figure 4. Testing Assays
Figure 5. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global PARP Inhibitor Biomarkers Testing Product Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global PARP Inhibitor Biomarkers Testing Product Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global PARP Inhibitor Biomarkers Testing Product Sales (2017-2028) & (K Units)
Figure 12. Global PARP Inhibitor Biomarkers Testing Product Price (2017-2028) & (US$/Unit)
Figure 13. Global PARP Inhibitor Biomarkers Testing Product Production Capacity (2017-2028) & (K Units)
Figure 14. Global PARP Inhibitor Biomarkers Testing Product Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. PARP Inhibitor Biomarkers Testing Product Market Drivers
Figure 16. PARP Inhibitor Biomarkers Testing Product Market Restraints
Figure 17. PARP Inhibitor Biomarkers Testing Product Market Trends
Figure 18. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturer in 2021
Figure 19. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Manufacturer in 2021
Figure 20. PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 PARP Inhibitor Biomarkers Testing Product Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 PARP Inhibitor Biomarkers Testing Product Manufacturer (Revenue) Market Share in 2021
Figure 23. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2028)
Figure 24. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2017-2028)
Figure 25. North America PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (USD Million)
Figure 26. Europe PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (USD Million)
Figure 28. South America PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (USD Million)
Figure 30. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
Figure 31. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
Figure 32. Global PARP Inhibitor Biomarkers Testing Product Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 34. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
Figure 35. Global PARP Inhibitor Biomarkers Testing Product Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
Figure 37. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 38. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2017-2028)
Figure 39. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2017-2028)
Figure 40. United States PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
Figure 44. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 45. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2017-2028)
Figure 46. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2017-2028)
Figure 47. Germany PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2017-2028)
Figure 56. China PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
Figure 63. South America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 64. South America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2017-2028)
Figure 65. South America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2017-2028)
Figure 66. Brazil PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2017-2028)
Figure 72. Turkey PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of PARP Inhibitor Biomarkers Testing Product in 2021
Figure 77. Manufacturing Process Analysis of PARP Inhibitor Biomarkers Testing Product
Figure 78. PARP Inhibitor Biomarkers Testing Product Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のPARP阻害剤バイオマーカー試験製品市場2022年：検査キット、検査アッセイ(Global PARP Inhibitor Biomarkers Testing Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のPARP阻害剤バイオマーカー試験製品市場2022年：検査キット、検査アッセイ

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp